$ANIK (Anika Therapeutics Inc)

$ANIK {{ '2015-12-10T12:07:09+0000' | timeago}} • Announcement

Therapeutic products maker $ANIK said the US FDA Office of Combination Products has allotted CINGAL, used to treat joint pain due to osteoarthritis, to the Center for Drug Evaluation and Research as the lead center for premarket review. Though $ANIK disagrees with FDA's decision, it intends to move swiftly to take CINGAL through regulatory review.

$MCK {{ '2017-07-21T16:07:44+0000' | timeago}} • Announcement

Biologics, a unit of healthcare technology firm $MCK, said it will join the limited distribution network of $PBYI to promote the latter’s kinase inhibitor Nerlynx. The formulation is indicated for treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$BDX {{ '2017-07-19T13:58:34+0000' | timeago}} • Announcement

$BDX received 510(k) clearance from the FDA for the BD FACSLyric flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitest assays for immunological assessment of individuals and patients having or suspected of having immune deficiency.

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$BAX {{ '2017-07-18T14:01:55+0000' | timeago}} • Announcement

The BoD of $BAX declared a quarterly dividend of $0.16 per share of its common stock. The dividend is payable on Oct 2, 2017, to stockholders of record as of Sept 1, 2017.

$ANIK {{ '2017-07-17T22:07:56+0000' | timeago}} • Announcement

$ANIK announced preliminary revenue for 2Q17. The company expects total revenue growth to be 23-26% YoY, including licensing, milestone and contract revenue of approx. $5MM as a result of the milestone payment associated with MONOVISC.

$ANIK {{ '2017-07-17T22:07:36+0000' | timeago}} • Announcement

$ANIK will receive a $5MM milestone payment under the terms of its license agreement with its US commercial partner. The milestone payment was triggered by MONOVISC achieving $100MM in US end-user sales within a consecutive 12-month period at the end of June 2017. The company will recognize this milestone payment as revenue in 2Q17.

$BAX {{ '2017-07-17T20:58:53+0000' | timeago}} • Announcement

$BAX appointed Cathy Smith, EVP and CFO of $TGT, to its BoD, bringing the total number of directors serving the company at this time to 13. Smith now also serves on $BAX's Audit Committee.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$CYH {{ '2017-07-12T11:46:04+0000' | timeago}} • Announcement

Hospital operator $CYH said its subsidiaries have signed a definitive agreement to sell Weatherford Regional Medical Center in Texas, and its associated assets, to the subsidiaries of $HCA. The transaction is expected to close later this year. The company is planning to divest a total of 30 hospitals.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

$EVHC {{ '2017-07-05T14:28:39+0000' | timeago}} • Announcement

$EVHC unit Envision Physician Services acquired multi-specialty group Infinity Healthcare, Inc., headquartered in Wisconsin. No other terms were disclosed.

$EVHC {{ '2017-07-05T13:18:41+0000' | timeago}} • Announcement

Healthcare services provider $EVHC said its subsidiary Envision Physician Services has acquired Northside Emergency Associates, an emergency medicine physician group practice. The company did not disclose financial details of the transaction.

$EVHC {{ '2017-06-30T12:14:40+0000' | timeago}} • Announcement

Healthcare firm $EVHC said the outstanding shares of its 5.25% series A-1 mandatory convertible preferred stock will automatically convert into common shares, effective  July 3, 2017. Each share of the preferred stock, unless previously converted, will automatically convert into 1.8141 shares of the common stock.

$EVHC {{ '2017-06-29T15:43:24+0000' | timeago}} • Announcement

$EVHC said its subsidiary Envision Physician Services acquired Anesthesia Associates of New London, P.C., a Connecticut-based anesthesia physician group practice. Envision Physician Services also expects to support growth of practice by recruiting additional physicians and certified registered nurse anesthetists to the group.

$AGN {{ '2017-06-27T13:15:55+0000' | timeago}} • Announcement

Pharma company $AGN launched Refresh Optive Mega-3, an over-the-counter artificial tear under the company’s Refresh portfolio. The formulation protects tears from evaporating while nourishing the damaged lipid layer and providing essential hydration to the tear film layers in patients suffering from ‘dry eye’.

$BAX {{ '2017-06-26T13:13:55+0000' | timeago}} • Announcement

$BAX has announced a bi-directional integration between its software solution DoseEdge Pharmacy Workflow Manager and the Epic Willow Inpatient Pharmacy System. The integration will help hospitals efficiently comply with requirements from the Centers for Medicare and Medicaid Services and other insurers.

$EVHC {{ '2017-06-14T13:44:43+0000' | timeago}} • Announcement

$EVHC commenced a process to increase outstanding borrowings under its existing Term Loan B credit facility by $500MM. These proceeds are expected to fund acquisition opportunities which are to be completed during 2Q17 and 3Q17. $EVHC also expects to repay any amounts outstanding under its current asset-based revolving credit facility at closing.

$BAX {{ '2017-06-14T12:53:57+0000' | timeago}} • Announcement

$BAX recently announced plans to expand its presence in the space with the pending acquisition of Claris Injectables. The acquisition of Claris is expected to close in 2H17. $BAX recently announced a strategic partnership with ScinoPharm to develop, manufacture and commercialize five generic injectables used in cancer treatment.

$BAX {{ '2017-06-14T12:50:42+0000' | timeago}} • Announcement

$BAX agreed with Dorizoe Lifesciences to facilitate accelerated development of more than 20 generic injectable products, including anti-infectives, oncolytics and cardiovascular medicines. Dorizoe will work with $BAX to perform certain product development activities, and $BAX will hold worldwide manufacturing and commercialization rights.

Recent Transcripts

NURO (NeuroMetrix Inc.)
Thursday, July 20 2017 - 12:00pm
ENZ (Enzo Biochem Inc.)
Friday, June 9 2017 - 12:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
ANIK (Anika Therapeutics Inc)
Thursday, May 4 2017 - 1:00pm
BDX (Becton, Dickinson and Company)
Thursday, May 4 2017 - 12:00pm
IRIX (IRIDEX Corporation)
Wednesday, May 3 2017 - 9:30pm
STAA (STAAR Surgical Company)
Wednesday, May 3 2017 - 8:30pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
CYH (Community Health Systems, Inc.)
Tuesday, May 2 2017 - 4:00pm
BDX (Becton, Dickinson and Company)
Tuesday, May 2 2017 - 12:00pm
LMNX (Luminex Corporation)
Monday, May 1 2017 - 8:30pm
HBIO (Harvard Bioscience Inc.)
Thursday, April 27 2017 - 8:30pm
SRDX (SurModics, Inc.)
Thursday, April 27 2017 - 12:30pm
AZN (AstraZeneca PLC)
Thursday, April 27 2017 - 11:00am
BAX (Baxter International Inc.)
Wednesday, April 26 2017 - 12:30pm
NUVA (NuVasive, Inc.)
Tuesday, April 25 2017 - 8:30pm
NURO (NeuroMetrix Inc.)
Thursday, April 20 2017 - 12:00pm

AlphaGraphics you may like